Richard A. Kayne

Insider Reports History

Signature
/s/ Richard A. Kayne
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Richard A. Kayne:

Company Role Class Num Shares Value Price $ Report Date Ownership
Eiger BioPharmaceuticals, Inc. 10%+ Owner Common Stock 5,375,225 $1,600,204 $0.2977 02 Nov 2023 Indirect

Insider Reports Filed by Richard A. Kayne

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000114036123051263-kayne-richard-a-2023-10-31 Eiger BioPharmaceuticals, Inc. 31 Oct 2023 5 +$72,815 4 10%+ Owner 02 Nov 2023, 21:21
/report/000114036123050238-kayne-richard-a-2023-10-18 Eiger BioPharmaceuticals, Inc. 18 Oct 2023 0 $0 3 10%+ Owner 30 Oct 2023, 16:53